Bharat Immunologicals & Biologicals Corp. Ltd. announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced sales was INR 82.809 million compared to INR 44.654 million a year ago. Net income was INR 183,000 compared to INR 4.981 million a year ago. Basic eps was INR 0 compared to INR 0.12 a year ago.